SAN DIEGO, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system disorders and pain, today announced that Stephen J. Farr, Ph.D., President, and Ann Rhoads, Chief Financial Officer, will be presenting at the Leerink Swann 2014 Global Healthcare Conference in New York on February 12, 2014.
Event: Leerink Swann 2014 Global Healthcare Conference Date: Wednesday, February 12, 2014 Place: New York City Time: 2:40 pm ET/ 11:40 am PTThe presentation will be webcast live and archived for 30 days on Zogenix' Investor Relations website at ir.zogenix.com. Dr. Farr and Ms. Rhoads will also be available to participate in one-on-one meetings at the conference. About Zogenix Zogenix, Inc. (Nasdaq:ZGNX), with offices in San Diego and Emeryville, California, is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with pain-related conditions and central nervous system disorders who need innovative treatment alternatives to help them return to normal daily functioning. The Company has commercialized two products using technology to enhance the patient experience and has a development pipeline that includes a once-monthly subcutaneous injection for schizophrenia. More information about Zogenix is available at www.zogenix.com FPR
CONTACT: INVESTORS: Zack Kubow | The Ruth Group 646.536.7020 | email@example.com MEDIA: Amy Wheeler | The Ruth Group 646.536.7025 | firstname.lastname@example.org